177 results on '"Maury, Wendy"'
Search Results
2. Envelope protein ubiquitination drives entry and pathogenesis of Zika virus
- Author
-
Giraldo, Maria I., Xia, Hongjie, Aguilera-Aguirre, Leopoldo, Hage, Adam, van Tol, Sarah, Shan, Chao, Xie, Xuping, Sturdevant, Gail L., Robertson, Shelly J., McNally, Kristin L., Meade-White, Kimberly, Azar, Sasha R., Rossi, Shannan L., Maury, Wendy, Woodson, Michael, Ramage, Holly, Johnson, Jeffrey R., Krogan, Nevan J., Morais, Marc C., Best, Sonja M., Shi, Pei-Yong, and Rajsbaum, Ricardo
- Published
- 2020
- Full Text
- View/download PDF
3. Infection-induced plasmablasts are a nutrient sink that impairs humoral immunity to malaria
- Author
-
Vijay, Rahul, Guthmiller, Jenna J., Sturtz, Alexandria J., Surette, Fionna A., Rogers, Kai J., Sompallae, Ramakrishna R., Li, Fengyin, Pope, Rosemary L., Chan, Jo-Anne, de Labastida Rivera, Fabian, Andrew, Dean, Webb, Lachlan, Maury, Wendy J., Xue, Hai-Hui, Engwerda, Christian R., McCarthy, James S., Boyle, Michelle J., and Butler, Noah S.
- Published
- 2020
- Full Text
- View/download PDF
4. Biomechanical characterization of TIM protein–mediated Ebola virus–host cell adhesion
- Author
-
Dragovich, Matthew A., Fortoul, Nicole, Jagota, Anand, Zhang, Wei, Schutt, Krista, Xu, Yan, Sanabria, Michelle, Moyer, Jr., Dennis M., Moller-Tank, Sven, Maury, Wendy, and Zhang, X. Frank
- Published
- 2019
- Full Text
- View/download PDF
5. Effect of Interferon Gamma on Ebola Virus Infection of Primary Kupffer Cells and a Kupffer Cell Line.
- Author
-
Aguilar-Briseño, José A., Elliff, Jonah M., Patten, Justin J., Wilson, Lindsay R., Davey, Robert A., Bailey, Adam L., and Maury, Wendy J.
- Subjects
KUPFFER cells ,EBOLA virus disease ,INTERFERON gamma ,ANTIVIRAL agents ,CELL lines ,INFECTION ,TYPE I interferons - Abstract
Ebola virus disease (EVD) represents a global health threat. The etiological agents of EVD are six species of Orthoebolaviruses, with Orthoebolavirus zairense (EBOV) having the greatest public health and medical significance. EVD pathogenesis occurs as a result of broad cellular tropism of the virus, robust viral replication and a potent and dysregulated production of cytokines. In vivo, tissue macrophages are some of the earliest cells infected and contribute significantly to virus load and cytokine production. While EBOV is known to infect macrophages and to generate high titer virus in the liver, EBOV infection of liver macrophages, Kupffer cells, has not previously been examined in tissue culture or experimentally manipulated in vivo. Here, we employed primary murine Kupffer cells (KC) and an immortalized murine Kupffer cell line (ImKC) to assess EBOV-eGFP replication in liver macrophages. KCs and ImKCs were highly permissive for EBOV infection and IFN-γ polarization of these cells suppressed their permissiveness to infection. The kinetics of IFN-γ-elicited antiviral responses were examined using a biologically contained model of EBOV infection termed EBOV ΔVP30. The antiviral activity of IFN-γ was transient, but a modest ~3-fold reduction of infection persisted for as long as 6 days post-treatment. To assess the interferon-stimulated gene products (ISGs) responsible for protection, the efficacy of secreted ISGs induced by IFN-γ was evaluated and secreted ISGs failed to block EBOV ΔVP30. Our studies define new cellular tools for the study of EBOV infection that can potentially aid the development of new antiviral therapies. Furthermore, our data underscore the importance of macrophages in EVD pathogenesis and those IFN-γ-elicited ISGs that help to control EBOV infection. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. The Role of Conserved N-Linked Glycans on Ebola Virus Glycoprotein 2
- Author
-
Lennemann, Nicholas J., Walkner, Madeline, Berkebile, Abigail R., Patel, Neil, and Maury, Wendy
- Published
- 2015
7. CD40 Signaling in Mice Elicits a Broad Antiviral Response Early during Acute Infection with RNA Viruses.
- Author
-
Rogers, Kai J., Richards, Paige T., Zacharias, Zeb R., Stunz, Laura L., Vijay, Rahul, Butler, Noah S., Legge, Kevin L., Bishop, Gail A., and Maury, Wendy
- Subjects
RNA virus infections ,PERITONEAL macrophages ,ANTIVIRAL agents ,EBOLA virus ,INTERFERON gamma ,INFLUENZA viruses ,INFLUENZA A virus - Abstract
Macrophages are critical in the pathogenesis of a diverse group of viral pathogens, both as targets of infection and for eliciting primary defense mechanisms. Our prior in vitro work identified that CD40 signaling in murine peritoneal macrophages protects against several RNA viruses by eliciting IL-12, which stimulates the production of interferon gamma (IFN-γ). Here, we examine the role of CD40 signaling in vivo. We show that CD40 signaling is a critical, but currently poorly appreciated, component of the innate immune response using two distinct infectious agents: mouse-adapted influenza A virus (IAV, PR8) and recombinant VSV encoding the Ebola virus glycoprotein (rVSV-EBOV GP). We find that stimulation of CD40 signaling decreases early IAV titers, whereas loss of CD40 elevated early titers and compromised lung function by day 3 of infection. Protection conferred by CD40 signaling against IAV is dependent on IFN-γ production, consistent with our in vitro studies. Using rVSV-EBOV GP that serves as a low-biocontainment model of filovirus infection, we demonstrate that macrophages are a CD40-expressing population critical for protection within the peritoneum and T-cells are the key source of CD40L (CD154). These experiments reveal the in vivo mechanisms by which CD40 signaling in macrophages regulates the early host responses to RNA virus infection and highlight how CD40 agonists currently under investigation for clinical use may function as a novel class of broad antiviral treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. A 2′FY-RNA Motif Defines an Aptamer for Ebolavirus Secreted Protein
- Author
-
Shubham, Shambhavi, Hoinka, Jan, Banerjee, Soma, Swanson, Emma, Dillard, Jacob A., Lennemann, Nicholas J., Przytycka, Teresa M., Maury, Wendy, and Nilsen-Hamilton, Marit
- Published
- 2018
- Full Text
- View/download PDF
9. TIM-family proteins inhibit HIV-1 release
- Author
-
Li, Minghua, Ablan, Sherimay D., Miao, Chunhui, Zheng, Yi-Min, Fuller, Matthew S., Rennert, Paul D., Maury, Wendy, Johnson, Marc C., Freed, Eric O., and Liu, Shan-Lu
- Published
- 2014
- Full Text
- View/download PDF
10. Structurally Different Yet Functionally Similar: Aptamers Specific for the Ebola Virus Soluble Glycoprotein and GP1,2 and Their Application in Electrochemical Sensing.
- Author
-
Banerjee, Soma, Hemmat, Mahsa Askary, Shubham, Shambhavi, Gosai, Agnivo, Devarakonda, Sivaranjani, Jiang, Nianyu, Geekiyanage, Charith, Dillard, Jacob A., Maury, Wendy, Shrotriya, Pranav, Lamm, Monica H., and Nilsen-Hamilton, Marit
- Subjects
APTAMERS ,EBOLA virus ,QUATERNARY structure ,MEMBRANE proteins ,AMINO acid sequence ,CARRIER proteins - Abstract
The Ebola virus glycoprotein (GP) gene templates several mRNAs that produce either the virion-associated transmembrane protein or one of two secreted glycoproteins. Soluble glycoprotein (sGP) is the predominant product. GP1 and sGP share an amino terminal sequence of 295 amino acids but differ in quaternary structure, with GP1 being a heterohexamer with GP2 and sGP a homodimer. Two structurally different DNA aptamers were selected against sGP that also bound GP1,2. These DNA aptamers were compared with a 2′FY-RNA aptamer for their interactions with the Ebola GP gene products. The three aptamers have almost identical binding isotherms for sGP and GP1,2 in solution and on the virion. They demonstrated high affinity and selectivity for sGP and GP1,2. Furthermore, one aptamer, used as a sensing element in an electrochemical format, detected GP1,2 on pseudotyped virions and sGP with high sensitivity in the presence of serum, including from an Ebola-virus-infected monkey. Our results suggest that the aptamers interact with sGP across the interface between the monomers, which is different from the sites on the protein bound by most antibodies. The remarkable similarity in functional features of three structurally distinct aptamers suggests that aptamers, like antibodies, have preferred binding sites on proteins. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. Ebola Virus Entry into Host Cells: Identifying Therapeutic Strategies
- Author
-
Rhein, Bethany A. and Maury, Wendy J.
- Published
- 2015
- Full Text
- View/download PDF
12. Transcutaneous DNA immunization following waxing-based hair depilation
- Author
-
Sloat, Brian R., Kiguchi, Kaoru, Xiao, Gang, DiGiovanni, John, Maury, Wendy, and Cui, Zhengrong
- Published
- 2012
- Full Text
- View/download PDF
13. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus
- Author
-
Kondratowicz, Andrew S., Lennemann, Nicholas J., Sinn, Patrick L., Davey, Robert A., Hunt, Catherine L., Moller-Tank, Sven, Meyerholz, David K., Rennert, Paul, Mullins, Robert F., Brindley, Melinda, Sandersfeld, Lindsay M., Quinn, Kathrina, Weller, Melodie, McCray, Paul B., Chiorini, John, and Maury, Wendy
- Published
- 2011
14. Selective Infection of Human CD4+ Cells by Simian Immunodeficiency Virus: Productive Infection Associated with Envelope Glycoprotein-Induced Fusion
- Author
-
Koenig, Scott, Hirsch, Vanessa M., Olmsted, Robert A., Powell, Douglas, Maury, Wendy, Rabson, Arnold, Fauci, Anthony S., Purcell, Robert H., and Johnson, Philip R.
- Published
- 1989
15. Tumor Necrosis Factor α Activates Human Immunodeficiency Virus Type 1 through Induction of Nuclear Factor Binding to the NF-κ B Sites in the Long Terminal Repeat
- Author
-
Duh, Elia J., Maury, Wendy J., Folks, Thomas M., Fauci, Anthony S., and Rabson, Arnold B.
- Published
- 1989
16. Effects of Magnesium on Intact Chloroplasts: II. Cation Specificity and Involvement of the Envelope ATPase in (Sodium) Potassium/Proton Exchange across the Envelope
- Author
-
Maury, Wendy J., Huber, Steven C., and Moreland, Donald E.
- Published
- 1981
17. Effects of Magnesium on Intact Chloroplasts. I. Evidence for Activation of (Sodium) Potassium/Proton Exchange across the Chloroplast Envelope
- Author
-
Huber, Steven C. and Maury, Wendy
- Published
- 1980
18. Echinacea in infection
- Author
-
Birt, Diane F, Widrlechner, Mark P, LaLone, Carlie A, Wu, Lankun, Bae, Jaehoon, Solco, Avery KS, Kraus, George A, Murphy, Patricia A, Wurtele, Eve S, Leng, Qiang, Hebert, Steven C, Maury, Wendy J, and Price, Jason P
- Published
- 2008
- Full Text
- View/download PDF
19. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus.
- Author
-
Ekanger, Camilla Tvedt, Zhou, Fan, Bohan, Dana, Lotsberg, Maria Lie, Ramnefjell, Maria, Hoareau, Laurence, Røsland, Gro Vatne, Lu, Ning, Aanerud, Marianne, Gärtner, Fabian, Salminen, Pirjo Riitta, Bentsen, Mariann, Halvorsen, Thomas, Ræder, Helge, Akslen, Lars A., Langeland, Nina, Cox, Rebecca, Maury, Wendy, Stuhr, Linda Elin Birkhaug, and Lorens, James B.
- Subjects
COVID-19 ,SARS-CoV-2 ,AIRWAY (Anatomy) ,VIRUS diseases - Abstract
The ongoing coronavirus disease 2019 (COVID-19) pandemic has led to the initiation of unprecedented research efforts to understand the pathogenesis mediated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). More knowledge is needed regarding the cell type-specific cytopathology and its impact on cellular tropism. Furthermore, the impact of novel SARS-CoV-2 mutations on cellular tropism, alternative routes of entry, the impact of co-infections, and virus replication kinetics along the respiratory tract remains to be explored in improved models. Most applied virology models are not well suited to address the remaining questions, as they do not recapitulate the histoarchitecture and cellular composition of human respiratory tissues. The overall aim of this work was to establish from single biopsy specimens, a human adult stem cell-derived organoid model representing the upper respiratory airways and lungs and explore the applicability of this model to study respiratory virus infection. First, we characterized the organoid model with respect to growth pattern and histoarchitecture, cellular composition, and functional characteristics. Next, in situ expression of viral entry receptors, including influenza virus-relevant sialic acids and SARS-CoV-2 entry receptor ACE2 and TMPRSS2, were confirmed in organoids of bronchiolar and alveolar differentiation. We further showed successful infection by pseudotype influenza A H7N1 and H5N1 virus, and the ability of the model to support viral replication of influenza A H7N1 virus. Finally, successful infection and replication of a clinical isolate of SARS-CoV-2 were confirmed in the organoids by TCID50 assay and immunostaining to detect intracellular SARS-CoV-2 specific nucleocapsid and dsRNA. The prominent syncytia formation in organoid tissues following SARS-CoV-2 infection mimics the findings from infected human tissues in situ. We conclude that the human organotypic model described here may be particularly useful for virology studies to evaluate regional differences in the host response to infection. The model contains the various cell types along the respiratory tract, expresses respiratory virus entry factors, and supports successful infection and replication of influenza virus and SARS-CoV-2. Thus, the model may serve as a relevant and reliable tool in virology and aid in pandemic preparedness, and efficient evaluation of antiviral strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
20. Phosphatidylserine receptors enhance SARS-CoV-2 infection.
- Author
-
Bohan, Dana, Van Ert, Hanora, Ruggio, Natalie, Rogers, Kai J., Badreddine, Mohammad, Aguilar Briseño, José A., Elliff, Jonah M., Rojas Chavez, Roberth Anthony, Gao, Boning, Stokowy, Tomasz, Christakou, Eleni, Kursula, Petri, Micklem, David, Gausdal, Gro, Haim, Hillel, Minna, John, Lorens, James B., and Maury, Wendy
- Subjects
COVID-19 ,SARS-CoV-2 ,CELL receptors ,VIRUS diseases ,HEPATITIS A virus ,APOPTOTIC bodies - Abstract
Phosphatidylserine (PS) receptors enhance infection of many enveloped viruses through virion-associated PS binding that is termed apoptotic mimicry. Here we show that this broadly shared uptake mechanism is utilized by SARS-CoV-2 in cells that express low surface levels of ACE2. Expression of members of the TIM (TIM-1 and TIM-4) and TAM (AXL) families of PS receptors enhance SARS-CoV-2 binding to cells, facilitate internalization of fluorescently-labeled virions and increase ACE2-dependent infection of SARS-CoV-2; however, PS receptors alone did not mediate infection. We were unable to detect direct interactions of the PS receptor AXL with purified SARS-CoV-2 spike, contrary to a previous report. Instead, our studies indicate that the PS receptors interact with PS on the surface of SARS-CoV-2 virions. In support of this, we demonstrate that: 1) significant quantities of PS are located on the outer leaflet of SARS-CoV-2 virions, 2) PS liposomes, but not phosphatidylcholine liposomes, reduced entry of VSV/Spike pseudovirions and 3) an established mutant of TIM-1 which does not bind to PS is unable to facilitate entry of SARS-CoV-2. As AXL is an abundant PS receptor on a number of airway lines, we evaluated small molecule inhibitors of AXL signaling such as bemcentinib for their ability to inhibit SARS-CoV-2 infection. Bemcentinib robustly inhibited virus infection of Vero E6 cells as well as multiple human lung cell lines that expressed AXL. This inhibition correlated well with inhibitors that block endosomal acidification and cathepsin activity, consistent with AXL-mediated uptake of SARS-CoV-2 into the endosomal compartment. We extended our observations to the related betacoronavirus mouse hepatitis virus (MHV), showing that inhibition or ablation of AXL reduces MHV infection of murine cells. In total, our findings provide evidence that PS receptors facilitate infection of the pandemic coronavirus SARS-CoV-2 and suggest that inhibition of the PS receptor AXL has therapeutic potential against SARS-CoV-2. Author summary: Phosphatidylserine (PS) receptors bind PS and mediate uptake of apoptotic bodies. Many enveloped viruses utilize this PS/PS receptor mechanism to adhere to and internalize into the endosomal compartment of cells. For viruses that have a mechanism(s) of endosomal escape, apoptotic mimicry is a productive route of virus entry. This clever use of this uptake mechanism by enveloped viruses is termed apoptotic mimicry. We evaluated if PS receptors serve as cell surface receptors for SARS-CoV-2 and found that the PS receptors, AXL, TIM-1 and TIM-4, facilitated virus infection when the SARS-CoV-2 cognate receptor, ACE2, was present. Consistent with the established mechanism of PS receptor utilization by other viruses, PS liposomes competed with SARS-CoV-2 for binding and entry. PS is readily detectable on the surface of SARS-CoV-2 virions, and contrary to prior reports we were unable to identify any interaction between AXL and SARS-CoV-2 spike. Pharmacological inhibition of AXL activity and knockout of AXL expression suggest it is the preferred PS receptor during SARS-CoV-2 entry. We propose that AXL is an under-appreciated but potentially important host factor facilitating SARS-CoV-2 entry. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
21. Ebolavirus: a brief review of novel therapeutic targets
- Author
-
Kondratowicz, Andrew S and Maury, Wendy J
- Published
- 2012
- Full Text
- View/download PDF
22. Regulation of equine infectious anemia virus expression
- Author
-
Maury, Wendy
- Published
- 1998
- Full Text
- View/download PDF
23. Enveloped RNA virus utilization of phosphatidylserine receptors: Advantages of exploiting a conserved, widely available mechanism of entry.
- Author
-
Bohan, Dana and Maury, Wendy
- Subjects
- *
RNA viruses , *MEMBRANE fusion , *T cells , *HEPATITIS A virus cellular receptors , *COVID-19 - Abstract
Enveloped virus utilization of PS receptors: Advantages and disadvantages of this functionall... One common viral lifestyle strategy that is benefited by the use of PS receptors is virus targeting of a wide variety of host species. As PS, PS receptor structure, and PS receptor function are highly conserved attributes among mammalian hosts and functionally conserved in insect hosts, the potential of PS receptors to facilitate zoonotic transmission under specific circumstances should not be ignored. Enveloped RNA virus entry is a conceptually simple stepwise process: A virus attaches to host cells, which leads to viral membrane/cellular membrane fusion and viral genome injection into the cytoplasm. While the inherent low-affinity interactions between PS and PS receptors is likely a disadvantage for a broad range of viruses to use this uptake mechanism, specific viruses are directly antagonized by PS receptors. [Extracted from the article]
- Published
- 2021
- Full Text
- View/download PDF
24. Echinacea in infection1-4
- Author
-
Birt, Diane F, Widrlechner, Mark P, LaLone, Carlie A, Wu, Lankun, Bae, Jaehoon, Solco, Avery KS, Kraus, George A, Murphy, Patricia A, Wurtele, Eve S, Leng, Qiang, Hebert, Steven C, Maury, Wendy J, and Price, Jason P
- Published
- 2008
25. Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR
- Author
-
Sedore, Stanley C., Byers, Sarah A., Biglione, Sebastian, Price, Jason P., Maury, Wendy J., and Price, David H.
- Published
- 2007
26. Cellular specificity of HIV-1 replication can be controlled by LTR sequences
- Author
-
Reed-Inderbitzin, Edward and Maury, Wendy
- Published
- 2003
- Full Text
- View/download PDF
27. Frontline Science: CD40 signaling restricts RNA virus replication in Mϕs, leading to rapid innate immune control of acute virus infection.
- Author
-
Rogers, Kai J., Shtanko, Olena, Stunz, Laura L., Mallinger, Laura N., Arkee, Tina, Schmidt, Megan E., Bohan, Dana, Brunton, Bethany, White, Judith M., Varga, Steve M., Butler, Noah S., Bishop, Gail A., and Maury, Wendy
- Subjects
VIRUS diseases ,RNA viruses ,VIRAL replication ,EBOLA virus ,VESICULAR stomatitis - Abstract
Many acute viral infections target tissue Mϕs, yet the mechanisms of Mϕ‐mediated control of viruses are poorly understood. Here, we report that CD40 expressed by peritoneal Mϕs restricts early infection of a broad range of RNA viruses. Loss of CD40 expression enhanced virus replication as early as 12–24 h of infection and, conversely, stimulation of CD40 signaling with an agonistic Ab blocked infection. With peritoneal cell populations infected with the filovirus, wild‐type (WT) Ebola virus (EBOV), or a BSL2 model virus, recombinant vesicular stomatitis virus encoding Ebola virus glycoprotein (rVSV/EBOV GP), we examined the mechanism conferring protection. Here, we demonstrate that restricted virus replication in Mϕs required CD154/CD40 interactions that stimulated IL‐12 production through TRAF6‐dependent signaling. In turn, IL‐12 production resulted in IFN‐γ production, which induced proinflammatory polarization of Mϕs, protecting the cells from infection. These CD40‐dependent events protected mice against virus challenge. CD40−/− mice were exquisitely sensitive to intraperitoneal challenge with a dose of rVSV/EBOV GP that was sublethal to CD40+/+ mice, exhibiting viremia within 12 h of infection and rapidly succumbing to infection. This study identifies a previously unappreciated role for Mϕ‐intrinsic CD40 signaling in controlling acute virus infection. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
28. Inhibition of HIV-1 infection by aqueous extracts of Prunella vulgaris L.
- Author
-
McCoy Joe-Ann, Qu Luping, Widrlechner Mark P, Brindley Melinda A, Price Jason, Oh ChoonSeok, Murphy Patricia, Hauck Cathy, and Maury Wendy
- Subjects
human immunodeficiency virus ,HIV ,antiviral ,microbicide ,plant extract ,self-heal ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background The mint family (Lamiaceae) produces a wide variety of constituents with medicinal properties. Several family members have been reported to have antiviral activity, including lemon balm (Melissa officinalis L.), sage (Salvia spp.), peppermint (Mentha × piperita L.), hyssop (Hyssopus officinalis L.), basil (Ocimum spp.) and self-heal (Prunella vulgaris L.). To further characterize the anti-lentiviral activities of Prunella vulgaris, water and ethanol extracts were tested for their ability to inhibit HIV-1 infection. Results Aqueous extracts contained more anti-viral activity than did ethanol extracts, displaying potent antiviral activity against HIV-1 at sub μg/mL concentrations with little to no cellular cytotoxicity at concentrations more than 100-fold higher. Time-of-addition studies demonstrated that aqueous extracts were effective when added during the first five hours following initiation of infection, suggesting that the botanical constituents were targeting entry events. Further analysis revealed that extracts inhibited both virus/cell interactions and post-binding events. While only 40% inhibition was maximally achieved in our virus/cell interaction studies, extract effectively blocked post-binding events at concentrations similar to those that blocked infection, suggesting that it was targeting of these latter steps that was most important for mediating inhibition of virus infectivity. Conclusions We demonstrate that aqueous P. vulgaris extracts inhibited HIV-1 infectivity. Our studies suggest that inhibition occurs primarily by interference of early, post-virion binding events. The ability of aqueous extracts to inhibit early events within the HIV life cycle suggests that these extracts, or purified constituents responsible for the antiviral activity, are promising microbicides and/or antivirals against HIV-1.
- Published
- 2011
- Full Text
- View/download PDF
29. Identification of light-independent inhibition of human immunodeficiency virus-1 infection through bioguided fractionation of Hypericum perforatum
- Author
-
Widrlechner Mark P, Murphy Patricia, Hauck Cathy, Carpenter Susan, Wills Nickolas, Wiemer David F, Neighbors Jeffrey D, Oh ChoonSeok, Brindley Melinda A, Price Jason P, Maury Wendy, Delate Kathleen, Kumar Ganesh, Kraus George A, Rizshsky Ludmila, and Nikolau Basil
- Subjects
Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background Light-dependent activities against enveloped viruses in St. John's Wort (Hypericum perforatum) extracts have been extensively studied. In contrast, light-independent antiviral activity from this species has not been investigated. Results Here, we identify the light-independent inhibition of human immunodeficiency virus-1 (HIV-1) by highly purified fractions of chloroform extracts of H. perforatum. Both cytotoxicity and antiviral activity were evident in initial chloroform extracts, but bioassay-guided fractionation produced fractions that inhibited HIV-1 with little to no cytotoxicity. Separation of these two biological activities has not been reported for constituents responsible for the light-dependent antiviral activities. Antiviral activity was associated with more polar subfractions. GC/MS analysis of the two most active subfractions identified 3-hydroxy lauric acid as predominant in one fraction and 3-hydroxy myristic acid as predominant in the other. Synthetic 3-hydroxy lauric acid inhibited HIV infectivity without cytotoxicity, suggesting that this modified fatty acid is likely responsible for observed antiviral activity present in that fraction. As production of 3-hydroxy fatty acids by plants remains controversial, H. perforatum seedlings were grown sterilely and evaluated for presence of 3-hydroxy fatty acids by GC/MS. Small quantities of some 3-hydroxy fatty acids were detected in sterile plants, whereas different 3-hydroxy fatty acids were detected in our chloroform extracts or field-grown material. Conclusion Through bioguided fractionation, we have identified that 3-hydroxy lauric acid found in field grown Hypericum perforatum has anti-HIV activity. This novel anti-HIV activity can be potentially developed into inexpensive therapies, expanding the current arsenal of anti-retroviral agents.
- Published
- 2009
- Full Text
- View/download PDF
30. Inhibition of lentivirus replication by aqueous extracts of Prunella vulgaris
- Author
-
Hauck Cathy, Murphy Patricia, McCoy Joe-Ann, Widrlechner Mark P, Brindley Melinda A, Rizshsky Ludmila, Nikolau Basil, and Maury Wendy
- Subjects
Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background Various members of the mint family have been used historically in Chinese and Native American medicine. Many of these same family members, including Prunella vulgaris, have been reported to have anti-viral activities. To further characterize the anti-lentiviral activities of P. vulgaris, water and ethanol extractions were tested for their ability to inhibit equine infectious anemia virus (EIAV) replication. Results Aqueous extracts contained more anti-viral activity than did ethanol extracts, displaying potent anti-lentiviral activity against virus in cell lines as well as in primary cell cultures with little to no cellular cytotoxicity. Time-of-addition studies demonstrated that the extracts were effective when added during the first four h of the viral life cycle, suggesting that the botanical constituents were targeting the virion itself or early entry events. Further analysis revealed that the extracts did not destroy EIAV virion integrity, but prevented viral particles from binding to the surface of permissive cells. Modest levels of anti-EIAV activity were also detected when the cells were treated with the extracts prior to infection, indicating that anti-EIAV botanical constituents could interact with both viral particles and permissive cells to interfere with infectivity. Size fractionation of the extract demonstrated that eight of the nine fractions generated from aqueous extracts displayed anti-viral activity. Separation of ethanol soluble and insoluble compounds in the eight active fractions revealed that ethanol-soluble constituents were responsible for the anti-viral activity in one fraction whereas ethanol-insoluble constituents were important for the anti-viral activity in two of the other fractions. In three of the five fractions that lost activity upon sub-fractionation, anti-viral activity was restored upon reconstitution of the fractions, indicating that synergistic anti-viral activity is present in several of the fractions. Conclusion Our findings indicate that multiple Prunella constituents have profound anti-viral activity against EIAV, providing additional evidence of the broad anti-viral abilities of these extracts. The ability of the aqueous extracts to prevent entry of viral particles into permissive cells suggests that these extracts may function as promising microbicides against lentiviruses.
- Published
- 2009
- Full Text
- View/download PDF
31. Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex
- Author
-
Nguyen Van Trung, Price Jason P, Byers Sarah A, Biglione Sebastian, Bensaude Olivier, Price David H, and Maury Wendy
- Subjects
Immunologic diseases. Allergy ,RC581-607 - Abstract
Abstract Background The positive transcription elongation factor, P-TEFb, comprised of cyclin dependent kinase 9 (Cdk9) and cyclin T1, T2 or K regulates the productive elongation phase of RNA polymerase II (Pol II) dependent transcription of cellular and integrated viral genes. P-TEFb containing cyclin T1 is recruited to the HIV long terminal repeat (LTR) by binding to HIV Tat which in turn binds to the nascent HIV transcript. Within the cell, P-TEFb exists as a kinase-active, free form and a larger, kinase-inactive form that is believed to serve as a reservoir for the smaller form. Results We developed a method to rapidly quantitate the relative amounts of the two forms based on differential nuclear extraction. Using this technique, we found that titration of the P-TEFb inhibitors flavopiridol, DRB and seliciclib onto HeLa cells that support HIV replication led to a dose dependent loss of the large form of P-TEFb. Importantly, the reduction in the large form correlated with a reduction in HIV-1 replication such that when 50% of the large form was gone, HIV-1 replication was reduced by 50%. Some of the compounds were able to effectively block HIV replication without having a significant impact on cell viability. The most effective P-TEFb inhibitor flavopiridol was evaluated against HIV-1 in the physiologically relevant cell types, peripheral blood lymphocytes (PBLs) and monocyte derived macrophages (MDMs). Flavopiridol was found to have a smaller therapeutic index (LD50/IC50) in long term HIV-1 infectivity studies in primary cells due to greater cytotoxicity and reduced efficacy at blocking HIV-1 replication. Conclusion Initial short term studies with P-TEFb inhibitors demonstrated a dose dependent loss of the large form of P-TEFb within the cell and a concomitant reduction in HIV-1 infectivity without significant cytotoxicity. These findings suggested that inhibitors of P-TEFb may serve as effective anti-HIV-1 therapies. However, longer term HIV-1 replication studies indicated that these inhibitors were more cytotoxic and less efficacious against HIV-1 in the primary cell cultures.
- Published
- 2007
- Full Text
- View/download PDF
32. Cell Specificity of the Transcription-Factor Repertoire Used by a Lentivirus: Motifs Important for Expression of Equine Infectious Anemia Virus in Nonmonocytic Cells
- Author
-
Maury, Wendy, Bradley, Sarahann, Wright, Brent, and Hines, Robert
- Published
- 2000
- Full Text
- View/download PDF
33. IL-4/IL-13 polarization of macrophages enhances Ebola virus glycoprotein-dependent infection.
- Author
-
Rogers, Kai J., Brunton, Bethany, Mallinger, Laura, Bohan, Dana, Sevcik, Kristina M., Chen, Jing, Ruggio, Natalie, and Maury, Wendy
- Subjects
EBOLA virus disease ,LECTINS ,PERITONEAL macrophages ,MACROPHAGES ,EBOLA virus ,CELL receptors ,PERITONEAL cancer ,IMMUNE reconstitution inflammatory syndrome - Abstract
Background: Ebolavirus (EBOV) outbreaks, while sporadic, cause tremendous morbidity and mortality. No therapeutics or vaccines are currently licensed; however, a vaccine has shown promise in clinical trials. A critical step towards development of effective therapeutics is a better understanding of factors that govern host susceptibility to this pathogen. As macrophages are an important cell population targeted during virus replication, we explore the effect of cytokine polarization on macrophage infection. Methods/Main findings: We utilized a BSL2 EBOV model virus, infectious, recombinant vesicular stomatitis virus encoding EBOV glycoprotein (GP) (rVSV/EBOV GP) in place of its native glycoprotein. Macrophages polarized towards a M2-like anti-inflammatory state by combined IL-4 and IL-13 treatment were more susceptible to rVSV/EBOV GP, but not to wild-type VSV (rVSV/G), suggesting that EBOV GP-dependent entry events were enhanced by these cytokines. Examination of RNA expression of known surface receptors that bind and internalize filoviruses demonstrated that IL-4/IL-13 stimulated expression of the C-type lectin receptor DC-SIGN in human macrophages and addition of the competitive inhibitor mannan abrogated IL-4/IL-13 enhanced infection. Two murine DC-SIGN-like family members, SIGNR3 and SIGNR5, were upregulated by IL-4/IL-13 in murine macrophages, but only SIGNR3 enhanced virus infection in a mannan-inhibited manner, suggesting that murine SIGNR3 plays a similar role to human DC-SIGN. In vivo IL-4/IL-13 administration significantly increased virus-mediated mortality in a mouse model and transfer of ex vivo IL-4/IL-13-treated murine peritoneal macrophages into the peritoneal cavity of mice enhanced pathogenesis. Significance: These studies highlight the ability of macrophage polarization to influence EBOV GP-dependent virus replication in vivo and ex vivo, with M2a polarization upregulating cell surface receptor expression and thereby enhancing virus replication. Our findings provide an increased understanding of the host factors in macrophages governing susceptibility to filoviruses and identify novel murine receptors mediating EBOV entry. Author summary: Ebola virus causes outbreaks in Central and West Africa, often resulting in high mortality rates. Macrophages are important cell targets for the virus, yet infection of these cells remains poorly understood. Here, we show that macrophages stimulated with the immunomodulatory cytokines IL-4 and IL-13 are significantly more susceptible than unstimulated cells to a model virus that expresses the Ebola virus glycoprotein. These cytokines increase virus entry by enhancing the expression of the cell surface receptors DC-SIGN in humans and SIGNR3 in mice. Blocking availability of those receptors reduced virus load. Consistent with an important role for macrophages during EBOV infection, reconstitution of mice with macrophages treated with IL-4 and IL-13 exacerbated virus pathogenesis. Our studies argue for the critical importance of the macrophages and their response to immunomodulatory cytokines in controlling the pathological consequences of Ebola virus glycoprotein-dependent infections and highlight an important aspect of filovirus/macrophage interaction that if controlled could decrease virus pathogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
34. HIV-1 Infection of First-Trimester and Term Human Placental Tissue: A Possible Mode of Maternal-Fetal Transmission [with Discussion]
- Author
-
Maury, Wendy, Potts, Barbara J., and Rabson, Arnold B.
- Published
- 1989
35. TIM-1 serves as a receptor for Ebola virus in vivo, enhancing viremia and pathogenesis.
- Author
-
Brunton, Bethany, Rogers, Kai, Phillips, Elisabeth K., Brouillette, Rachel B., Bouls, Ruayda, Butler, Noah S., and Maury, Wendy
- Subjects
EBOLA virus ,VESICULAR stomatitis ,VIRUS diseases ,PATHOGENIC viruses ,T cells ,HEPATITIS A virus cellular receptors - Abstract
Background: T cell immunoglobulin mucin domain-1 (TIM-1) is a phosphatidylserine (PS) receptor, mediating filovirus entry into cells through interactions with PS on virions. TIM-1 expression has been implicated in Ebola virus (EBOV) pathogenesis; however, it remains unclear whether this is due to TIM-1 serving as a filovirus receptor in vivo or, as others have suggested, TIM-1 induces a cytokine storm elicited by T cell/virion interactions. Here, we use a BSL2 model virus that expresses EBOV glycoprotein to demonstrate the importance of TIM-1 as a virus receptor late during in vivo infection. Methodology/Principal findings: Infectious, GFP-expressing recombinant vesicular stomatitis virus encoding either full length EBOV glycoprotein (EBOV GP/rVSV) or mucin domain deleted EBOV glycoprotein (EBOV GPΔO/rVSV) was used to assess the role of TIM-1 during in vivo infection. GFP-expressing rVSV encoding its native glycoprotein G (G/rVSV) served as a control. TIM-1-sufficient or TIM-1-deficient BALB/c interferon α/β receptor
-/- mice were challenged with these viruses. While G/rVSV caused profound morbidity and mortality in both mouse strains, TIM-1-deficient mice had significantly better survival than TIM-1-expressing mice following EBOV GP/rVSV or EBOV GPΔO/rVSV challenge. EBOV GP/rVSV or EBOV GPΔO/rVSV in spleen of infected animals was high and unaffected by expression of TIM-1. However, infectious virus in serum, liver, kidney and adrenal gland was reduced late in infection in the TIM-1-deficient mice, suggesting that virus entry via this receptor contributes to virus load. Consistent with higher virus loads, proinflammatory chemokines trended higher in organs from infected TIM-1-sufficient mice compared to the TIM-1-deficient mice, but proinflammatory cytokines were more modestly affected. To assess the role of T cells in EBOV GP/rVSV pathogenesis, T cells were depleted in TIM-1-sufficient and -deficient mice and the mice were challenged with virus. Depletion of T cells did not alter the pathogenic consequences of virus infection. Conclusions: Our studies provide evidence that at late times during EBOV GP/rVSV infection, TIM-1 increased virus load and associated mortality, consistent with an important role of this receptor in virus entry. This work suggests that inhibitors which block TIM-1/virus interaction may serve as effective antivirals, reducing virus load at late times during EBOV infection. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
36. The role of mononuclear phagocytes in Ebola virus infection.
- Author
-
Rogers, Kai J. and Maury, Wendy
- Subjects
FILOVIRIDAE ,EBOLA virus ,MACROPHAGES ,DENDRITIC cells ,VIRUS diseases - Abstract
Abstract: The filovirus, Zaire Ebolavirus (EBOV), infects tissue macrophages (Mϕs) and dendritic cells (DCs) early during infection. Viral infection of both cells types is highly productive, leading to increased viral load. However, virus infection of these two cell types results in different consequences for cellular function. Infection of Mϕs stimulates the production of proinflammatory and immunomodulatory cytokines and chemokines, leading to the production of a cytokine storm, while simultaneously increasing tissue factor production and thus facilitating disseminated intravascular coagulation. In contrast, EBOV infection of DCs blocks DC maturation and antigen presentation rendering these cells unable to communicate with adaptive immune response elements. Details of the known interactions of these cells with EBOV are reviewed here. We also identify a number of unanswered questions that remain about interactions of filoviruses with these cells. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
37. Synthesis of chroman aldehydes that inhibit HIV
- Author
-
Kraus, George A., Mengwasser, John, Maury, Wendy, and Oh, ChoonSeok
- Published
- 2011
- Full Text
- View/download PDF
38. TIM1 (HAVCR1): an Essential "Receptor" or an "Accessory Attachment Factor" for Hepatitis A Virus?
- Author
-
Das, Anshuman, Maury, Wendy, and Lemon, Stanley M.
- Subjects
- *
HEPATITIS A virus , *VIRAL hepatitis , *MARBURG virus , *HEPATITIS A virus cellular receptors - Published
- 2019
- Full Text
- View/download PDF
39. Interferon-γ Inhibits Ebola Virus Infection.
- Author
-
Rhein, Bethany A., Powers, Linda S., Rogers, Kai, Anantpadma, Manu, Singh, Brajesh K., Sakurai, Yasuteru, Bair, Thomas, Miller-Hunt, Catherine, Sinn, Patrick, Davey, Robert A., Monick, Martha M., and Maury, Wendy
- Subjects
INTERFERONS ,ANTINEOPLASTIC agents ,ANTIVIRAL agents ,EBOLA virus disease ,HEMORRHAGIC fever - Abstract
Ebola virus outbreaks, such as the 2014 Makona epidemic in West Africa, are episodic and deadly. Filovirus antivirals are currently not clinically available. Our findings suggest interferon gamma, an FDA-approved drug, may serve as a novel and effective prophylactic or treatment option. Using mouse-adapted Ebola virus, we found that murine interferon gamma administered 24 hours before or after infection robustly protects lethally-challenged mice and reduces morbidity and serum viral titers. Furthermore, we demonstrated that interferon gamma profoundly inhibits Ebola virus infection of macrophages, an early cellular target of infection. As early as six hours following in vitro infection, Ebola virus RNA levels in interferon gamma-treated macrophages were lower than in infected, untreated cells. Addition of the protein synthesis inhibitor, cycloheximide, to interferon gamma-treated macrophages did not further reduce viral RNA levels, suggesting that interferon gamma blocks life cycle events that require protein synthesis such as virus replication. Microarray studies with interferon gamma-treated human macrophages identified more than 160 interferon-stimulated genes. Ectopic expression of a select group of these genes inhibited Ebola virus infection. These studies provide new potential avenues for antiviral targeting as these genes that have not previously appreciated to inhibit negative strand RNA viruses and specifically Ebola virus infection. As treatment of interferon gamma robustly protects mice from lethal Ebola virus infection, we propose that interferon gamma should be further evaluated for its efficacy as a prophylactic and/or therapeutic strategy against filoviruses. Use of this FDA-approved drug could rapidly be deployed during future outbreaks. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
40. Ebola Virus Entry: A Curious and Complex Series of Events.
- Author
-
Moller-Tank, Sven and Maury, Wendy
- Subjects
- *
EBOLA viral disease transmission , *EBOLA virus , *NUCLEOPROTEINS , *DENDRITIC cells , *VIRION , *VIRAL vaccines - Abstract
The article discusses the significance of the series of events which lead up to the entry of the Ebola virus (EBOV) into the human body. Topics include the outbreak of EBOV in new geographic regions and the need for a vaccine, how the virions initiate the Infection by entering macrophages and dendritic cells and the structure of the EBOV particle which includes viral glycoprotein and and viral ribonucleoprotein complex.
- Published
- 2015
- Full Text
- View/download PDF
41. Phosphatidylserine receptors: Enhancers of enveloped virus entry and infection.
- Author
-
Moller-Tank, Sven and Maury, Wendy
- Subjects
- *
PHOSPHATIDYLSERINES , *PROTEIN receptors , *VIRAL envelope proteins , *DNA viruses , *RNA viruses , *BILAYER lipid membranes , *VIRUS diseases , *CAPSIDS - Abstract
A variety of both RNA and DNA viruses envelop their capsids in a lipid bilayer. One of the more recently appreciated benefits this envelope is incorporation of phosphatidylserine (PtdSer). Surface exposure of PtdSer disguises viruses as apoptotic bodies; tricking cells into engulfing virions. This mechanism is termed apoptotic mimicry. Several PtdSer receptors have been identified to enhance virus entry and we have termed this group of proteins PtdSer-mediated virus entry enhancing receptors or PVEERs. These receptors enhance entry of a range of enveloped viruses. Internalization of virions by PVEERs provides a broad mechanism of entry with little investment by the virus itself. PVEERs may allow some viruses to attach to cells, thereby making viral glycoprotein/cellular receptor interactions more probable. Alternatively, other viruses may rely entirely on PVEERs for internalization into endosomes. This review provides an overview of PtdSer receptors that serve as PVEERs and the biology behind virion/PVEER interaction. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
42. Filovirus Entry: A Novelty in the Viral Fusion World.
- Author
-
Hunt, Catherine L., Lennemann, Nicholas J., and Maury, Wendy
- Subjects
RNA viruses ,GLYCOPROTEINS ,EPITHELIAL cells ,MEMBRANE glycoproteins ,CELL membranes - Abstract
Ebolavirus (EBOV) and Marburgvirus (MARV) that compose the filovirus family of negative strand RNA viruses infect a broad range of mammalian cells. Recent studies indicate that cellular entry of this family of viruses requires a series of cellular protein interactions and molecular mechanisms, some of which are unique to filoviruses and others are commonly used by all viral glycoproteins. Details of this entry pathway are highlighted here. Virus entry into cells is initiated by the interaction of the viral glycoprotein1 subunit (GP
1 ) with both adherence factors and one or more receptors on the surface of host cells. On epithelial cells, we recently demonstrated that TIM-1 serves as a receptor for this family of viruses, but the cell surface receptors in other cell types remain unidentified. Upon receptor binding, the virus is internalized into endosomes primarily via macropinocytosis, but perhaps by other mechanisms as well. Within the acidified endosome, the heavily glycosylated GP1 is cleaved to a smaller form by the low pH-dependent cellular proteases Cathepsin L and B, exposing residues in the receptor binding site (RBS). Details of the molecular events following cathepsin-dependent trimming of GP1 are currently incomplete; however, the processed GP1 specifically interacts with endosomal/lysosomal membranes that contain the Niemann Pick C1 (NPC1) protein and expression of NPC1 is required for productive infection, suggesting that GP/NPC1 interactions may be an important late step in the entry process. Additional events such as further GP1 processing and/or reducing events may also be required to generate a fusion-ready form of the glycoprotein. Once this has been achieved, sequences in the filovirus GP2 subunit mediate viral/cellular membrane fusion via mechanisms similar to those previously described for other enveloped viruses. This multi-step entry pathway highlights the complex and highly orchestrated path of internalization and fusion that appears unique for filoviruses. [ABSTRACT FROM AUTHOR]- Published
- 2012
- Full Text
- View/download PDF
43. Inhibition of HIV-1 infection by aqueous extracts of Prunella vulgaris L.
- Author
-
ChoonSeok Oh, Price, Jason, Brindley, Melinda A., Widrlechner, Mark P., Luping Qu, McCoy, Joe-Ann, Murphy, Patricia, Hauck, Cathy, and Maury, Wendy
- Subjects
LAMIACEAE ,PRUNELLA vulgaris ,ANTIVIRAL agents ,ANTINEOPLASTIC antibiotics ,LEMON balm ,BASIL - Abstract
Background: The mint family (Lamiaceae) produces a wide variety of constituents with medicinal properties. Several family members have been reported to have antiviral activity, including lemon balm (Melissa officinalis L.), sage (Salvia spp.), peppermint (Mentha × piperita L.), hyssop (Hyssopus officinalis L.), basil (Ocimum spp.) and selfheal (Prunella vulgaris L.). To further characterize the anti-lentiviral activities of Prunella vulgaris, water and ethanol extracts were tested for their ability to inhibit HIV-1 infection. Results: Aqueous extracts contained more anti-viral activity than did ethanol extracts, displaying potent antiviral activity against HIV-1 at sub μg/mL concentrations with little to no cellular cytotoxicity at concentrations more than 100-fold higher. Time-of-addition studies demonstrated that aqueous extracts were effective when added during the first five hours following initiation of infection, suggesting that the botanical constituents were targeting entry events. Further analysis revealed that extracts inhibited both virus/cell interactions and post-binding events. While only 40% inhibition was maximally achieved in our virus/cell interaction studies, extract effectively blocked post-binding events at concentrations similar to those that blocked infection, suggesting that it was targeting of these latter steps that was most important for mediating inhibition of virus infectivity. Conclusions: We demonstrate that aqueous P. vulgaris extracts inhibited HIV-1 infectivity. Our studies suggest that inhibition occurs primarily by interference of early, post-virion binding events. The ability of aqueous extracts to inhibit early events within the HIV life cycle suggests that these extracts, or purified constituents responsible for the antiviral activity, are promising microbicides and/or antivirals against HIV-1. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
44. Hypericum in infection: Identification of anti-viral and anti-inflammatory constituents.
- Author
-
Birt, Diane F., Widrlechner, Mark P., Hammer, Kimberly D. P., Hillwig, Matthew L., Wei, Jingqiang, Kraus, George A., Murphy, Patricia A., McCoy, Joe-Ann, Wurtele, Eve S., Neighbors, Jeffrey D., Wiemer, David F., Maury, Wendy J., and Price, Jason P.
- Subjects
HYPERICUM ,ECHINACEA (Plants) ,ANTI-inflammatory agents ,FLAVONOIDS ,ANTHOCYANIDINS - Abstract
The Iowa Center for Research on Botanical Dietary Supplements seeks to optimize Echinacea, Hypericum, and Prunella botanical supplements for human-health benefit, emphasizing anti-viral, anti-inflammatory, and anti-pain activities. This mini-review reports on ongoing studies on Hypericum. The Center uses the genetically diverse, well-documented Hypericum populations collected and maintained at the USDA-ARS North Central Regional Plant Introduction Station (NCRPIS), and the strength of research in synthetic chemistry at Iowa State University to tap natural diversity, to help discover key constituents and interactions among constituents that impact bioactivity and toxicity. The NCRPIS has acquired more than 180 distinct populations of Hypericum, with a focus on Hypericum perforatum L. (Hypericaceae), representing about 13% of currently recognized taxa. Center chemists have developed novel synthetic pathways for key flavones, acyl phloroglucinols, hyperolactones, and a tetralin that have been found in Hypericum, and these compounds are used as standards and for bioactivity studies. Both light-dependent and light-independent anti-viral activities have been identified by using bioactivity-guided fractionation of H. perforatum and a HIV-1 infection test system. Our Center has focused on light-independent activity, potentially due to novel chemicals, and polar fractions are undergoing further fractionation. Anti-inflammatory activity has been found to be light-independent, and fractionation of a flavonoid-rich extract revealed four compounds (amentoflavone, chlorogenic acid, pseudohypericin, and quercetin) that interacted in the light to inhibit lipopolysaccharide-induced prostaglandin E
2 activity. The Center continues to explore novel populations of H. perforatum and related species to identify constituents and interactions of constituents that contribute to potential health benefits related to infection. [ABSTRACT FROM AUTHOR]- Published
- 2009
- Full Text
- View/download PDF
45. Inhibition of lentivirus replication by aqueous extracts of Prunella vulgaris.
- Author
-
Brindley, Melinda A., Widrlechner, Mark P., McCoy, Joe-Ann, Murphy, Patricia, Hauck, Cathy, Rizshsky, Ludmila, Nikolau, Basil, and Maury, Wendy
- Subjects
LENTIVIRUS diseases ,PRUNELLA vulgaris ,ANTIVIRAL agents ,CELL lines ,CELL-mediated cytotoxicity - Abstract
Background: Various members of the mint family have been used historically in Chinese and Native American medicine. Many of these same family members, including Prunella vulgaris, have been reported to have anti-viral activities. To further characterize the anti-lentiviral activities of P. vulgaris, water and ethanol extractions were tested for their ability to inhibit equine infectious anemia virus (EIAV) replication. Results: Aqueous extracts contained more anti-viral activity than did ethanol extracts, displaying potent anti-lentiviral activity against virus in cell lines as well as in primary cell cultures with little to no cellular cytotoxicity. Time-of-addition studies demonstrated that the extracts were effective when added during the first four h of the viral life cycle, suggesting that the botanical constituents were targeting the virion itself or early entry events. Further analysis revealed that the extracts did not destroy EIAV virion integrity, but prevented viral particles from binding to the surface of permissive cells. Modest levels of anti-EIAV activity were also detected when the cells were treated with the extracts prior to infection, indicating that anti-EIAV botanical constituents could interact with both viral particles and permissive cells to interfere with infectivity. Size fractionation of the extract demonstrated that eight of the nine fractions generated from aqueous extracts displayed anti-viral activity. Separation of ethanol soluble and insoluble compounds in the eight active fractions revealed that ethanol-soluble constituents were responsible for the anti-viral activity in one fraction whereas ethanol-insoluble constituents were important for the anti-viral activity in two of the other fractions. In three of the five fractions that lost activity upon sub-fractionation, anti-viral activity was restored upon reconstitution of the fractions, indicating that synergistic anti-viral activity is present in several of the fractions. Conclusion: Our findings indicate that multiple Prunella constituents have profound anti-viral activity against EIAV, providing additional evidence of the broad anti-viral abilities of these extracts. The ability of the aqueous extracts to prevent entry of viral particles into permissive cells suggests that these extracts may function as promising microbicides against lentiviruses. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
46. Drug induced superinfection in HIV and the evolution of drug resistance
- Author
-
Leontiev, Vladimir V., Maury, Wendy J., and Hadany, Lilach
- Subjects
- *
HIV , *DRUG resistance , *VIRAL disease treatment , *AIDS treatment , *VIRUSES , *ANTIVIRAL agents - Abstract
Abstract: The rapid evolution of HIV drug resistance is a major cause of AIDS treatment failure. Superinfection, the infection of an already infected cell by additional virions, can be a major factor contributing to the evolution of drug resistance. However, the pattern and consequences of superinfection in HIV populations are far from fully understood. In this paper we study the implications of the fact that superinfection is regulated by HIV. We propose that superinfection is negatively associated with the success of the virus, so that more successful viruses are less likely to allow superinfection. We use computational models to investigate the effect that regulated superinfection would have on the evolution of drug resistance in HIV population. We find that regulated, fitness-associated superinfection can provide a distinct advantage to the virus in adapting to anti-HIV drugs in comparison with unregulated superinfection. Based on the results of the computational models and on current biological evidence, we suggest that the mechanism of fitness-associated regulation of coinfection in HIV is plausible, and that its investigation can lead to new ways to fight viral drug resistance. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
47. Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex.
- Author
-
Biglione, Sebastian, Byers, Sarah A., Price, Jason P., Nguyen, Van Trung, Bensaude, Olivier, Price, David H., and Maury, Wendy
- Subjects
HIV ,RNA polymerases ,CYCLINS ,HELA cells ,VIRAL replication ,VIROLOGY - Abstract
Background: The positive transcription elongation factor, P-TEFb, comprised of cyclin dependent kinase 9 (Cdk9) and cyclin T1, T2 or K regulates the productive elongation phase of RNA polymerase II (Pol II) dependent transcription of cellular and integrated viral genes. P-TEFb containing cyclin T1 is recruited to the HIV long terminal repeat (LTR) by binding to HIV Tat which in turn binds to the nascent HIV transcript. Within the cell, P-TEFb exists as a kinase-active, free form and a larger, kinase-inactive form that is believed to serve as a reservoir for the smaller form. Results: We developed a method to rapidly quantitate the relative amounts of the two forms based on differential nuclear extraction. Using this technique, we found that titration of the P-TEFb inhibitors flavopiridol, DRB and seliciclib onto HeLa cells that support HIV replication led to a dose dependent loss of the large form of P-TEFb. Importantly, the reduction in the large form correlated with a reduction in HIV-1 replication such that when 50% of the large form was gone, HIV-1 replication was reduced by 50%. Some of the compounds were able to effectively block HIV replication without having a significant impact on cell viability. The most effective P-TEFb inhibitor flavopiridol was evaluated against HIV-1 in the physiologically relevant cell types, peripheral blood lymphocytes (PBLs) and monocyte derived macrophages (MDMs). Flavopiridol was found to have a smaller therapeutic index (LD50/IC50) in long term HIV-1 infectivity studies in primary cells due to greater cytotoxicity and reduced efficacy at blocking HIV-1 replication. Conclusion: Initial short term studies with P-TEFb inhibitors demonstrated a dose dependent loss of the large form of P-TEFb within the cell and a concomitant reduction in HIV-1 infectivity without significant cytotoxicity. These findings suggested that inhibitors of P-TEFb may serve as effective anti-HIV-1 therapies. However, longer term HIV-1 replication studies indicated that these inhibitors were more cytotoxic and less efficacious against HIV-1 in the primary cell cultures. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
48. Endocytosis and a Low-pH Step Are Required for Productive Entry of Equine Infectious Anemia Virus.
- Author
-
Brindley, Melinda A. and Maury, Wendy
- Subjects
- *
ENDOCYTOSIS , *PINOCYTOSIS , *ANEMIA , *RETROVIRUSES , *MACROPHAGES , *AMMONIUM , *THERAPEUTICS - Abstract
Recently, it has become evident that entry of some retroviruses into host cells is dependent upon a Vesicle-localized, low-pH step. The entry mechanism of equine infectious anemia virus (EIAV) has yet to be examined. Here, we demonstrate that wild-type strains of EIAV require a low-pH step for productive entry. Lysosomotropic agents that inhibit the acidification of internal vesicles inhibited productive entry of EIAV. The presence of ammonium chloride (30 mM), monensin (30 μM), or bafilomycin A (50 nM) in the medium dramatically decreased the number of EIAV antigen-positive cells. We found that a low-pH step was required for EIAV infection of tissue culture cell lines as well as primary cells, such as endothelial cells and monocyte-derived macrophages. The ammonium chloride treatment did not reduce virion stability, nor did the treatment prevent virion binding to cells. Consistent with a requirement for a low-pH step, virion infectivity was enhanced more than threefold by brief low-pH treatment following binding of viral particles to permissive cells. A superinfecting variant strain of EIAV, vMA-1c, did not require a low-pH step for productive infection of fibroblasts. However, lysosomotropic agents were inhibitory to vMA-1c infection in the other cell types that vMA-1c infected but did not superinfect, indicating that the entry pathway used by vMA-1c for superinfection abrogates the need for the low-pH step. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
49. Evolution of the Equine Infectious Anemia Virus Long Terminal Repeat during the Alteration of Cell Tropism.
- Author
-
Maury, Wendy, Thompson, Robert J., Jones, Quentin, Bradley, Sarahann, Denke, Tara, Baccam, Prasith, Smazik, Matthew, and Oaks, J. Lindsay
- Subjects
- *
LENTIVIRUSES , *ANEMIA , *MICROSATELLITE repeats , *AMINO acids , *TRANSCRIPTION factors , *TROPISMS - Abstract
Equine infectious anemia virus (EIAV) is a lentivirus with in vivo cell tropism primarily for tissue macrophages; however, in vitro the virus can be adapted to fibroblasts and other cell types. Tropism adaptation is associated with both envelope and long terminal repeat (LTR) changes, and findings strongly suggest that these regions of the genome influence cell tropism and virulence. Furthermore, high levels of genetic variation have been well documented in both of these genomic regions. However, specific EIAV nucleotide or amino acid changes that are responsible for cell tropism changes have not been identified. A study was undertaken with the highly virulent, macrophage-tropic strain of virus EIAVwyo to identify LTR changes associated with alterations in cell tropism. We found the stepwise generation of a new transcription factor binding motif within the enhancer that was associated with adaptation of EIAV to endothelial cells and fibroblasts. An LTR that contained the new motif had enhanced transcriptional activity in fibroblasts, whereas the new site did not alter LTR activity in a macrophage cell line. This finding supports a previous prediction that selection for new LTR genetic variants may be a consequence of cell-specific selective pressures. Additional investigations of the EIAVwyo LTR were performed in vivo to determine if LTR evolution could be detected over the course of a 3-year infection. Consistent with previous in vivo findings, we observed no changes in the enhancer region of the LTR over that time period, indicating that the EIAVwyo LTR was evolutionarily stable in vivo. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
50. Characterization of a Cytolytic Strain of Equine Infectious Anemia Virus.
- Author
-
Maury, Wendy, Wright, Patrick J., and Bradley, Sarahann
- Subjects
- *
EQUINE infectious anemia , *VIRUSES - Abstract
A novel strain of equine infectious anemia virus (EIAV) called vMA-1c that rapidly and specifically killed infected equine fibroblasts (ED cells) but not other infectible cell lines was established. This strain was generated from an avirulent, noncytopathic strain of EIAV, MA-1. Studies with this new cytolytic strain of virus have permitted us to define viral parameters associated with EIAV-induced cell killing and begin to explore the mechanism, vMA-1c infection resulted in induction of rapid cell death, enhanced fusogenic activity, and increased rates of spread in equine fibroblasts compared to other strains of EIAV. The highly cytolytic nature of vMA-1c suggested that this strain might be superinfecting equine fibroblasts. Receptor interference studies demonstrated that prior infection of equine fibroblasts with EIAV did not alter the ability of vMA-1c to infect and kill these cells. In similar studies in a canine fibroblast cell line, receptor interference did occur, vMA-1c infection of equine fibroblasts was also associated with large quantities of unintegrated viral DNA, a well-established hallmark of retroviral superinfection. Cloning of the vMA-1c genome identified nucleotide changes that would result in at least one amino acid change in all viral proteins. A chimeric infectious molecular clone containing the vMA-1c tat, S2, and env open reading frames recapitulated most of the characteristics of vMA-1c, including superinfection, fibroblast killing, and fusogenic activity. In summary, in vitro selection for a strain of EIAV that rapidly killed cells resulted in the generation of a virus that was able to superinfect these cells, presumably by the use of a novel mechanism of cell entry. This phenotype mapped to the 3' half of the genome. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.